PRELUDD-PAYMENT-SERVICES
Preludd Payment Services, a leading player in the instore payment industry, has strengthened its service offering and entered the Global market by acquiring Amadis.
Preludd Payment Services, has completed the acquisition of Amadis, a leading provider of EMV card-present payment acceptance solutions. With this acquisition, the company now offers solutions at all stages of the payment chain for payment solution providers, banks, acquirers, payment terminal distributors and SoftPOS.
The combination of Preludd and Amadis will create a future market leader in payment solutions.
Connecting payment terminals
Founded in 2016, Preludd offers a white-label cloud-based payment platform that securely connects POS terminals in France. As a payment platform, the company forwards payment data from POS terminals to banks and private acquirers. It also facilitates POS terminal fleets and associated SIM cards management and logistics.
A strategic acquisition
The acquisition of Amadis will enable the two entities to leverage their skills to serve a common ambition: the emergence of a leading player in Global payment solutions, with priority given to SoftPOS. Amadis is a payment card software development company providing EMV payment acceptance solutions on off the shelf systems (COTS) like smartphones and tablets and also PCI POS terminal hardware.
The company provides out-of-the-box compliance software that implements the global standards and requirements of all global payment networks. It has a world-class client portfolio and its solutions are deployed globally.
By leveraging Amadis' 18 years of experience, Preludd will be able to offer new and innovative solutions to make payments more accessible to everyone around the world.
With Amadis based in North America, Preludd in France and Middle-East, the group has a presence that allows it to be as close as possible to global issues.
Key figures
Preludd / Amadis
- Over 78 million connections are routed to banks each month
- +290,000 terminals connected
- + 7.5 billion euros in transit each month
- + 60 employees who are experts in electronic payments
- 100% coverage of the global EMV payment networks
- Technology present in +55 million banking terminals & SoftPOS
- Goal to reach more than 10 million euros in turnover by 2025
About Preludd Payment Services
Preludd is a cloud-based white label payment gateway. Our PCI-DSS hosted infrastructure securely connects retail outlets to international payment networks and routes millions of transactions per month to banks. More information on https://preludd.com/
About Amadis
Amadis provides card processing software and secure payment acceptance solutions, including SoftPOS, to payment terminal manufacturers and service providers. Amadis develops its software according to standards (such as EMVco, PCI and Nexo) for universal and agnostic compliance. More information on https://www.amadis.ca/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005009/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 10:53:00 CET | Press release
This marks Stafford’s second timberland fund at over USD 1 Billion in 2025, backed by strong existing investor support and new capital commitments from global institutional investors Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 09:55:00 CET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 09:00:00 CET | Press release
The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to optimise potential therapeutic NANOBODY® proteins for multiple new targets LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited abo
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 07:09:00 CET | Press release
WPP Turkey has been selected as a pilot partner to deploy GoWit One, cutting campaign setup time to 10 minutes. GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 07:00:00 CET | Press release
‘BBB’ long-term issuer credit rating from S&P Global RatingsPositive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvementRecognition of Galderma’s science-based dermatology portfolio and global operations Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom